ResearcherHarbin Medical UniversityNo recent work listed
Tao Zhang
Matched on ORCID iD 0000-0002-7409-4690; OpenAlex author ID A5115602155. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 24
2021: 1 paper · 2022: 1 paper · 2023: 2 papers
Papers 4
- Tumor Cell Derived Lnc-FSD2-31:1 Contributes to Cancer-Associated Fibroblasts Activation in Pancreatic Ductal Adenocarcinoma Progression through Extracellular … Co-author DOI 10.1002/advs.202203324↗
- Metabolic Reprogramming:Application of lipid metabolism related genes in the risk model of clinical prognosis of pancreatic cancer Co-author DOI 10.21203/rs.3.rs-3744911/v1↗
- Positive feedback regulation of lncRNA TPT1-AS1 and ITGB3 promotes cell growth and metastasis in pancreatic cancer. Co-author DOI 10.1111/cas.15388↗
- Beneficial Diets and Pancreatic Cancer: Molecular Mechanisms and Clinical Practice. First author DOI 10.3389/fonc.2021.630972↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hongze Chen · 3 shared papers, 2021–2023 · strength 0.39
- Paper Tumor Cell Derived Lnc-FSD2-31:1 Contributes to Cancer-Associated Fibroblasts Activation in Pancreatic Ductal Adenocarc… DOI 10.1002/advs.202203324↗
- Paper Beneficial Diets and Pancreatic Cancer: Molecular Mechanisms and Clinical Practice. DOI 10.3389/fonc.2021.630972↗
- Paper Positive feedback regulation of lncRNA TPT1-AS1 and ITGB3 promotes cell growth and metastasis in pancreatic cancer. DOI 10.1111/cas.15388↗
- Lei Zhao · 1 shared paper, 2023 · strength 0.39
- Xinglong Geng · 2 shared papers, 2021–2023 · strength 0.27
- Yongwei Wang · 2 shared papers, 2021–2023 · strength 0.27
- Guanqun Li · 2 shared papers, 2021–2023 · strength 0.27
- Wenbo Yang · 2 shared papers, 2021–2023 · strength 0.27
- Bei Sun · 2 shared papers, 2021–2023 · strength 0.27
- Chundong Cheng · 2 shared papers, 2022–2023 · strength 0.27
- Le Li · 2 shared papers, 2022–2023 · strength 0.27
- Zhongjie Zhao · 2 shared papers, 2022–2023 · strength 0.27
- Jisheng Hu · 2 shared papers, 2022–2023 · strength 0.27
- Danxi Liu · 2 shared papers, 2022–2023 · strength 0.27
- Xuewei Bai · 1 shared paper, 2023 · strength 0.14
- Gang Wang · 1 shared paper, 2023 · strength 0.14
- Yangyang Zhang · 1 shared paper, 2023 · strength 0.14
- Yang Zhang · 1 shared paper, 2021 · strength 0.13
- Le Li · 1 shared paper, 2021 · strength 0.13
- Bei Sun · 1 shared paper, 2022 · strength 0.13
- Yongwei Wang · 1 shared paper, 2022 · strength 0.13
- Shangha Pan · 1 shared paper, 2022 · strength 0.13
- Yilong Li · 1 shared paper, 2022 · strength 0.13
- Gang Wang · 1 shared paper, 2022 · strength 0.13
- Rui Kong · 1 shared paper, 2022 · strength 0.13
- Zonglin Liu · 1 shared paper, 2022 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.